Health care agenda missing from the inaugural address and on the new White House website.
The practice, which has been criticized by some gun groups, is not addressed in the health law and federal courts have so far upheld doctors’ rights.
State lawmaker says he was worried the Trump Administration would use information on those who purchased plans to try and deport them.
From nutrition assistance programs to preventing food-borne illness, the Agriculture Department is keenly involved in health policy.
Acting CMS administrator Andy Slavitt is taking to social media to defend the Affordable Care Act from GOP dismantling.
Effort asks salon owners to voluntarily improve air quality and use less toxic chemicals.
The Physicians Committee for Responsible Medicine, which eschews meat and pushes for nutrition to have a stronger influence in health policy, is suggesting alterations in how food aid to low income people is structured.
Patients who depend on the state-run AIDS Drug Assistance Program are having trouble getting medical appointments and life-saving medications.
Covered California sent the wrong subsidy information to insurers, who charged most consumers less than they really owed. Now they have to pay up.
Donald Trump’s pick to run HHS has been under fire for trading health care stocks but at least six senators at his confirmation hearings also own such stocks.
Federal officials release names of insurers who ranked poorly in a recent review of their online directories’ accuracy.
More hospitals, including Montefiore Medical Center in New York, are setting up support centers to help stressed-out family members cope.
An analysis by the Congressional Budget Office offers an estimate of the effects of the repeal plan offered by congressional Republican in 2015, which may be a blueprint for efforts currently underway to overhaul the health law.
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
With the future of Obamacare on the line, workers might want to consider what benefits they have gained through the landmark law.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Ending federal support of the group that helps supply women’s reproductive health care could complicate health law overhaul efforts.
Follow the twists and turns of the orphan drug industry over the past three decades.
Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.
The former Congressman championed the Orphan Drug Act decades ago but now he fears it’s being manipulated to make money.